This inventor holds 6 USPTO granted patents. Top assignees: Swedish Orphan Biovitrum Ag, Swedish Orphen Biovitrum Ag. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Geneva, CH (2021)
- Basel, CH (2022)
Company Filing History:
Years Active: 2021-2025
Title: Walter Ferlin: Innovator in Medical Treatments
Introduction
Walter Ferlin is a notable inventor based in Geneva, Switzerland. He has made significant contributions to the field of medical treatments, particularly in relation to interferon-gamma related indications. With a total of 6 patents to his name, Ferlin's work has the potential to impact the lives of many patients suffering from various disorders.
Latest Patents
Ferlin's latest patents include innovative methods and compositions aimed at treating or preventing conditions associated with elevated levels of interferon-gamma (IFN-γ). One of his key disclosures focuses on methods, compositions, and dosing regimens for alleviating symptoms related to elevated IFN-γ levels. Another important patent addresses the diagnosis and treatment of disorders in patients with elevated levels of CXCL9 and other biomarkers. This includes methods for treating hemophagocytic lymphohistiocytosis (HLH) and other related conditions by utilizing agents that interfere with or antagonize IFN-γ signaling.
Career Highlights
Throughout his career, Walter Ferlin has worked with prominent companies in the pharmaceutical industry, including Swedish Orphan Biovitrum AG. His expertise in developing treatments for complex medical conditions has established him as a respected figure in his field.
Collaborations
Ferlin has collaborated with esteemed colleagues such as Fabrizio De Benedetti and Cristina De Min. These partnerships have further enhanced his research and development efforts in the medical field.
Conclusion
Walter Ferlin's contributions to medical innovations, particularly in the treatment of disorders related to interferon-gamma, highlight his role as a significant inventor. His ongoing work continues to pave the way for advancements in medical treatments that can improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile